When an account no longer needs access to be able to manage the content, the Editor role can be removed.
The account can be made inaccessible by changing the associated email and resetting the password to a complex, system generated password.
The account can also be deleted, but there would be no archive record of the account for historical or audit purposes.
These are the instructions to create a new Content Editor account.
| Co-chairs Ben Freedman Emma Svennberg |
CLOSED SESSION FOR AF-SCREEN MEMBERS AND INDUSTRY SUPPORTERS Zoom Session Request Password |
| Ben Freedman | Welcome and introduction |
| Lena Rivard | Dementia and AF Screening White paper |
| Emma Svennberg | Progress of ongoing large screening studies with hard outcome endpoints |
| Jeff Healey | Meta-analysis and meta-regression of studies with hard endpoints: Status of Prospero Paper |
| Giuseppe Boriani | Survey: wearables/devices and consumer-led screening |
| Axel Brandes Stavros Stavrakis |
Consumer-led AF Screening White paper |
| Renate Schnabel | AF-SCREEN Future Activities and Horizon 2020/AFFECT-EU programme update |
| Co-Chairs Jeff Healey Renate Schnabel |
OPEN SESSION ON AF SCREENING MP4 4.7 GB download |
| Ben Freedman | Year in Review for AF-SCREEN and Screening for AF |
| Mike Gibson | Heartline study update (Janssen J&J/Bayer/Apple watch) |
| Søren Diederichsen | Simulations from the Danish Loop Study: relevance to other screening methodologies |
| Peter Noseworthy | AI and Machine Learning using eMR, biomarkers and 12-lead ECG to predict AF and AF-related events |
| Emelia Benjamin | What are the research priorities in screening for AF |
Please save the date for our next AF-SCREEN annual meeting on Saturday August 31, 2019 in Paris, during the ESC.
| Ben Freedman | Year in review: Screening for Atrial Fibrillation |
| Mårten Rosenqvist | Update on current and planned outcome studies |
| Jonathan Mant | Status of UK primary care screening study |
| John Eikelboom | Covert AF in Vascular Prevention Trials: Lessons from COMPASS and NAVIGATE ESUS – [download will be available early 2019] |
| Barbara Casadei | UK Biobank study |
| Jeff Healey | Treatment of subclinical AF |
| Renate Schnabel Ben Freedman |
Controversies and key points for post-stroke white paper |
| Mintu Turakhia | Testing new AF screening methods at scale – [slides not available – more information is available at this link] |
| Ben Freedman | Future activities and meetings |
| Featured Symposium: B-013 | Contemporary Management of Atrial Fibrillation: Stroke Prevention |
| A. J. Camm | Selection of Oral Anticoagulant Agents for Thromboembolic Prophylaxis in Non-Valvular Atrial Fibrillation |
| B. Freedman | Screening for Asymptomatic AF in the Population (Without Implanted Devices): Where Do We Stand?” |
| J. S. Healey | Subclinical AF Detected By Implanted Devices: Should We Anticoagulate? |
| H. Calkins | Should Oral Anticoagulation Be Discontinued Following AF Ablation? |
If you want to add any items to this list, please email cspin.admin@phri.ca
| Date | Time | Title | Speaker | Location | Session |
| Sat Aug 25 | 9:00-10:30 | AFib – Stroke Prevention Symposium | Chaired by M. Ezekowitz, L. Fauchier | Madrid Village 6 | Symposium |
| Sun Aug 26 | 10:05-10:55 | AF SMART: Electronic tools and system for atrial fibrillation screening in general practice: automated prompts, electronic decision support and data extraction, all integrated with clinical software | J Orchard | Exhibition 3 | Digital Health Stage |
| Sun Aug 26 | 11:45 | Identifying the undiagnosed AF patient through ‘Know Your Pulse’ community pharmacy based events held in ten countries during Arrhythmia Alliance World Heart Rhythm Week 2017 | N. Breakwell | Agora 2 – Agora | Rapid Fire Abstract |
| Sun Aug 26 | 12:03 | Mass screening for atrial fibrillation using n-terminal pro b-type natriuretic peptide – preliminary results from the strokestop 2 study | K. Kemp Gudmundsdottir | Agora 2 – Agora | Rapid Fire Abstract |
| Sun Aug 26 | 8:30 – 12:30 | A comparison of intermittent and continuous event recording in population screening for atrial fibrillation | T. Fredriksson | Poster Area | Poster Session 2 |
| Sun Aug 26 | 8:30 – 12:30 | Assessment of N-terminal pro-brain natriuretic peptide level in the screening for atrial fibrillation in the primary health care | F. Ghazal | Poster Area | Poster Session 2 |
| Sun Aug 26 | 8:30 – 12:30 | Use of a smartphone electrocardiogram, electronic prompts and electronic decision support for atrial fibrillation screening in metropolitan general practices | J. Orchard | Poster Area | Poster Session 2 |
| Sun Aug 26 | 8:30 – 12:30 | Comparing atrial fibrillation detection algorithms in smart devices on validated mobile ECG data | J. Eckstein | Poster Area | Poster Session 2 |
| Sun Aug 26 | 14:00 – 18:00 | Clinical characteristics of an elderly population with screening-detected elevated NT-proBNP levels without previous diagnosis of heart failure or atrial fibrillation (Substudy of STROKESTOP II) | F. Al-Khalili | Poster Area | Session 3 P2797 |
| Mon Aug 27 | 8.30-10.00 | Handheld ECG devices for the detection of atrial fibrillation – State of the art | N. Lowres | Digital Health Stage- Exhibition 3 | Chronic nursing care symposium |
| Mon Aug 27 | 8.30-10.00 | Handheld ECG devices for the detection of atrial fibrillation – The role of the nurse and allied health professionals. | L. Neubeck | Digital Health Stage- Exhibition 3 | Chronic nursing care symposium |
| Mon Aug 27 | 08:30 – 10:00 | AFib – The “Big Picture” | Chaired by R. Schilling, C. Blomstrom-Lundqvist | Madrid Village 6 | Special Session |
| Mon Aug 27 | 11:00 | Screening for atrial fibrillation: modern alternatives | L. Neubeck | Madrid Village 6 | Chronic nursing care symposium |
| Mon Aug 27 | 13:00 – 14:00 | Spectrum of non-valvular atrial fibrillation: burden of disease | Chaired by J. Camm | Bratislava – Village 2 | Satellite symposium |
| Mon Aug 27 | 13:00 | Stroke prevention – How broad is the spectrum of atrial fibrillation? | J. Camm | Bratislava – Village 2 | Satellite symposium |
| Mon Aug 27 | 13:15 | Roadmap for AF detection – Why, where and how to search? | B. Freedman | Bratislava – Village 2 | Satellite symposium |
| Mon Aug 27 | 13:55 | Panel discussion – Spectrum of non-valvular atrial fibrillation: burden of disease. | Chaired by J. Camm, B. Freedman | Bratislava – Village 2 | Satellite symposium |
| Tue Aug 28 | 14:00-18:00 | Implementation of screening for atrial fibrillation in general practice with a single-lead ECG: A cluster randomized controlled trial | F. Kaasenbrood | Poster Area | Poster Session 7 |
| Tue Aug 28 | 14:00-18:00 | Pulse palpation and history of palpitations in atrial fibrillation screening – preliminary results from the strokestop 2 study | K. Kemp Gudmundsdottir | Poster Area | Poster Session 7 |
| J. Camm | Welcome and Introduction to AF-SCREEN |
| E. Svennberg | Single Time Point, Incidental Clinical Detection, Patient Activated |
| G. Boriani J. Healey |
Continuous Recordings Implanted/External |
| C. Albert | Patients vs Population, Risk Enchancement vs Simple Age Criteria |
| R. Sandhu | Settings to Screen: Community, Pharmacy, Clinic |
| M. Rosenqvist | Simple Inexpensive Methods Actionable AF |
| J. Wang | Non USA/Non Europe Perspective |
| R. Schnabel | What Size of Study is Required to Impact Guidelines |
| H. Calkins | AHA/ACC/HRS Guidelines |
| G. Lip | ACCP and APSC and NICE Guidelines |
| B. Freedman | Closing Remarks |
| Ben Freedman | Year in review: Screening for Atrial Fibrillation |
| Jeff Healey | Setting the stage: What is needed to move the field forward |
| Mårten Rosenqvist | Summary of ongoing and planned studies |
| Shrikant Bangdiwala | Statistical considerations: pooling of data and meta regression |
| Jonathan Mant | Stakeholder engagement |
| Spreadsheet of large AF screening outcome trials and other studies |
